We have successfully developed and marketed a wide range of prescription products since the 1980s including, Actonel, Asacol, Enablex, Dantrium, Dantrium IV, Didronel, Macrobid, Macrodantin, Entex, and Ziac.
 As one of Procter & Gamble’s diverse healthcare businesses, we benefit from the consumer understanding of the world’s largest marketing company. P&G also manufactures and markets a variety of over-the-counter and oral care products such as Crest®, Oral-B®, Prilosec OTC®, Vicks®, Metamucil®, Pepto-Bismol® and ThermaCare®.
We are focused on three therapeutic areas:
- Musculoskeletal
Therapeutic areas of special interest include osteoporosis, rheumatoid arthritis and osteoarthritis.
- Gastrointestinal
Therapeutic areas of special interest include ulcerative colitis, Crohn’s disease, Irritable Bowel Syndrome (IBS), and Gastroesophageal Reflux Disease (GERD).
- Women's Health
Therapeutic areas of special interest include overactive bladder, incontinence (urge and stress), menopausal symptoms and other products directed towards women’s health areas with high consumer involvement.
These are therapeutic areas that align with broader P&G strategies, and in which we have proven capabilities. Additionally, P&G’s expertise in consumer understanding and marketing uniquely enables us to excel in these therapeutic areas.
 With decades of experience, on-the-ground operations in 22 countries including the U.S., Canada and all major markets throughout Western Europe, we have built a highly innovative organization with world class talent in scientific development and marketing. Our people are driven by a desire to understand and address the needs of consumers and health care professionals around the world.
|
